The recognition that cancers are linked in many cases to social and economic disparities parallels the epidemic emergence o f these diseases.
In 1935 Brunet classified cancer together with alcoholism as being social diseases in the same way that infectious diseases like syphilis, tuberculosis, and leprosy were considered social.
Cancers o f the uterus, by the nature o f the differential patterns o f incidence and mortality associated with race, ethnicity, and socioeconomic status clearly exhibit a sociological pattern. Thus, a policy review o f cervical cancer control has to consider social welfare as much as individual behavior. The distribution o f cervical cancer in the population also reflects the distribution o f resources and needs-medical and otherwisein our society, with regard to both causality and the degree to which diagnosed cancers are successfully treated.
Today, there are roughly 16,000 newly diagnosed cases and 4 ,0 0 0 deaths from cervical cancer in the United States per year (Sondik et al. 1987 ). In the overall scheme o f health and disease in the population, this number o f deaths is not high; it represents only about 1 percent of all cancer deaths. In some ways, it represents a great success. The decline o f cervical cancer mortality is one o f the most encouraging examples o f cancer control (Ellwein 1978 ). Yet, much emphasis is given to this disease; it is included as one o f the five specific objectives for cancer control in the United States for the period o f 1985 to 2000 (Greenwald and Sondik 1986) . Surely part o f this emphasis stems from the fact that an effective control technology exists in the form of Pap smears for early detection. And just as surely, part o f this emphasis stems from the largely unstated but intuitively accepted knowledge that today's deaths from cervical cancer represent a social inequity for which the public health professions share a sense o f responsibility and a desire to overcome.
The fundamental policy questions that must be addressed with regard to cervical cancer are: •
• How far toward eradication can society move? Iceland, with a homogeneous, very small, and extremely literate population (about 270,000), has been able to eradicate cervical cancer mortality for all practical purposes (Johannesson, Geirsson, and Day 1978) .
Thus, eradication can be theoretically achieved. In another long term public health effort in British Columbia, however, the results have been impressive but not as encouraging. After actively screening T A B L E 1 Age-standardized Cervix Uteri , Incidence Rates per 100,000
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practical terms, what then should we expect as a minimum level o f feasible control in the United States, with its large size, het erogeneous population, and cumbersome medical care system? • How far toward eradication is society willing to move? This political question is outside the realm o f this article and is resolved only though the equitable allocation o f resources. The willingness to spend on cervical cancer control ultimately is indicative of the extent to which society is willing to spend resources on the needs o f the disadvantaged.
Indeed, cervical cancer is a mirror o f-or represents in microcosmsocial development. It is a sentinel event for a broader public health problem (Howard 1987) . Today, it increasingly mirrors the inequity in resource distribution between rich and poor countries, between north and south. More and more, cervical cancer is emerging as a major cause o f death in major female population segments in developing countries, where incidence rates may be 3 to 5 times the rates for white American women (table 1) (Waterhouse 1982) . This reflects, in part, the ability to control infectious diseases, the ability to diagnose and register cervical cancer (which is inexpensive), and the inability to treat (which is expensive). Thus, the gap between black and whitepoor and nonpoor-in the United States-and what to do about itand the gap between poor and rich nations have many parallel features. Therefore, while this article is about the United States, its broader extension and relevance should be obvious.
A Conceptual Model for Cancer Control
The paths to prevention are traditionally conceptualized as either primary or secondary. Primary prevention activities address risk factors that predispose the individual to cancer development. Reduction in these risk factors should result in a reduction in cancer incidence.
Secondary prevention activities address risk factors that predispose to mortality without affecting incidence directly. Thus, the focus is on enhancing the duration o f survival after a cancer diagnosis through improved detection, diagnosis, and treatment. Mortality rates are influenced by both changes in incidence rates associated with primary prevention strategies and in survival rates associated with secondary prevention methods.
This article does not deal with primary prevention o f cervical cancer for the following reasons:
Etiologic data on cervical cancer are not consistent and the excess risks identified for any particular risk factor are relatively low (Hulka 1982) .
The major risk factors that have been suggested-notably sexual practices, poor hygiene, and viral infections-are not readily ad dressed by categorical prevention programs. At least, to date, no categorical cervical cancer prevention programs exist to be drawn on as examples.
The reductions in incidence rates in Western nations that have taken place in the last four decades cannot be accounted for by any specific public health eflFort. Rather, they are probably associated with general socioeconomic development which has afforded better health practices in general, such as nutrition and hygiene as affected by both social change and greater citizen awareness (Devesa 1984 ).
Secondary prevention efforts will be dealt with extensively. The main model that is used draws on the tradition o f health services research (Myers 1965) . The major risk factors for cancer mortality that are addressed by secondary prevention can be categorized as: access, availability quality, continuity, and compliance with regard to the delivery and use o f health and medical care services.
The paths to cancer prevention and control may be general and population-wide or they may be targeted at special population segments where risk is great. These are trade-off considerations that are madeoften implicitly-in policy. A relatively small level o f change in either incidence or mortality distributed over a broad population base may have a greater effect in terms o f absolute numbers than a large level o f change in a small population segment. Cervical cancer control clearly falls into the category where targeted approaches directed at high-risk populations are required.
Cervical Cancer in the United States Epidem iological C lassijicatio n Problem
There are inconsistencies in the classification o f cervical cancer data, which may affect some o f the analysis o f this problem:
Numerator Problems. Although microscopic confirmation o f all di agnoses now exceeds 98 percent for both whites and blacks in the United States, 7 to 9 percent o f all histologic classifications are unspecified carcinoma (Baquet et al. 1986 Angeles has suggested that 25 percent o f the decline in cervical cancer mortality may be attributed to the increased performance o f total hysterectomies (Stern et al. 1977 Rarely is this done, however.
Age-specific and race-specific rates are, therefore, preferred to stan dardized or adjusted rates when attempting to understand, particularly for policy purposes, patterns o f cancer in the population. Figure 1 presents age-specific incidence and mortality rates for cervical cancer in whites and blacks in the United States. W hile the age-specific rates are lower for whites than for blacks in all age categories, there are very dramatic increases in both incidence and mortality rates in older- aged blacks, while the rates remain more stable for whites after age 30. Given the latency periods associated with cervical cancer, sequential age-specific cohort analysis may be important to monitor changes in social and behavioral patterns (related to policy initiatives or otherwise) and how these might affect rates in different age groups in the future.
The use o f age-standardized or adjusted rates would not provide a clear understanding o f these nuances.
D escriptive C ervical Cancer S ta tistic s
The following data are derived from the National Cancer Institute SEER (Surveillance Epidemiology and End Results) program, a pop ulation-based cancer incidence and survival reporting program which involves eleven population-based tumor registries. This program is described in detail elsewhere (Sondik et al. 1987; Baquet et al. 1986 ).
The following data refer only to invasive cervical cancer. They do not include in situ cases.
A ge-adjusted Incidence R ates, 1 9 7 5 to 1 9 8 4
Black females have higher age-adjusted incidence rates when compared to their white counterparts (table 2) . Age-adjusted cervical cancer incidence has decreased in black and white females during the period of 1975 to 1984. Although decreases have occurred for both groupsand more so among black women than white women-black women continue to have higher incidence rates. During this period incidence rates decreased by 4 1.4 percent (6.1 percent annually) in blacks and 25.8 percent in whites (a 4 .0 percent annual decrease). In 1975 ageadjusted incidence was 27.6 per 100,000 population in black females compared to 11.0 in whites. In 1984 incidence was 16.0 and 8.1 in black and white females respectively.
Age-Specific Incidence
Age-specific incidence rates have decreased also during 1975 to 1984 for most age groups for both blacks and whites. The age-specific rates for invasive cervical cancer, however, increases more for blacks as age advances. Black women have over 200 percent higher incidence than whites in the 70-plus age category.
A ge-adjusted M o rta lity , 1 9 7 5 to 1 9 8 4
Cervical cancer mortality is also higher in blacks. In 1975 the ageadjusted mortality rate was 11.0 per 100,000 in blacks and 3.9 in whites. Although decreases have occurred during the referenced time period, differences in mortality persist. In 1984 the mortality rate for blacks was 7.5 per 100,000 compared to 2.8 in females. During the period o f 1975 to 1984, the age-adjusted mortality rates for both blacks and whites declined by roughly the same proportion, that is, 27.8 percent and 28.1 percent respectively (table 3) .
Five-year R elative S u rv iv a l
The five-year relative survival rate for the time period o f 1974 to 1982 was 61.2 percent for blacks and 68 percent for whites (table  4) . Survival differences also exist within stage (extent o f disease) for blacks and whites. Caution is advisable when interpreting these rates 
Risk Factors for Secondary Prevention
It is possible to identify some factors associated with the adequacy (or inadequacy) o f secondary prevention strategies as practiced today.
For example, in 1970 a national survey o f women under the age of 45 who had ever been married found that approximately 10 percent had never had a Pap test. The rate o f those never having had a Pap test was twice as high in the black population as in the white population.
Having had a Pap test was significantly related to education and family income (Rochat 1976) . Based on data from the 1973 National Health Interview Survey, Kleinman and Kopstein (1981) indicating that the women probably did not feel that cervical cancer was a great risk or that cervical screening was worthwhile (Misczynski and Stern 1979) . Alternatively, a report on work-site cervical cancer found that convenience o f screening is a significant factor that influenced participation rates, and that (at least in Australia) the workplace may be a good place to conduct screening because o f its convenience for working women (Raphael 1977) .
The Potential for Cervical Cancer Control
As the previous section indicates, cervical cancer incidence and mortality rates have declined steadily during the past 30 years (Devesa 1984) .
Nevertheless, disparities continue to exist between whites and blacks for both incidence and mortality rates. The differences for incidence are approximately two-fold, while the differences for mortality are about three-fold. The magnitude o f the differentials has not declined appreciably during this period. N or can the difference in mortality rates be accounted for by the differences in incidence rates alone; among incident cases blacks clearly experience poorer survival rates than whites. There are no apparent host or biological explanations for why the cervical cancer survival differences persist. Consequently, a substantial reason appears to be the inequitable distribution o f health and medical resources (i.e., quality treatment) between blacks and whites.
The V alue o f E a r lie r Detection
About one-third o f cervical cancer cases detected are at stage II or higher. Given the significantly reduced survival associated with the more advanced stages, there clearly is room for improvement. The significantly poorer rates that blacks experience further suggest that targeted approaches to early detection and follow-up could produce improved survival.
Programs o f screening and early detection can have a significant impact even where the baseline of cervical cancer incidence and mortality are low. The Scandinavian countries exemplify this. These homogeneous, socioeconomically advanced populations are served by national health systems that have significantly eliminated the problem o f access to and availability o f health care services. Nevertheless, within Sweden there has been a marked decline in advanced-stage disease associated with cervical cancer screening (Stenkvist et al. 1984) . Among the Scandinavian nations, cervical cancer mortality rates in Norway have not declined as rapidly as in the other Scandinavian nations. Norway was alone in not instituting vigorous programs o f cervical cancer screening (Day 1984) . This suggests that it should be possible to accelerate the decline in advanced-stage disease for both whites and blacks in the United States through targeted aggressive promotion of cervical cancer screening.
C r itic a l F actors in Secondary Prevention
Analysis o f factors that have contributed to avoidable mortality from cervical cancer is fairly complete. The main risk factors for poor survival include the following: Lack o f Pap Smears. The Pap smear has been well established by scientific concensus and extensive research to be an effective and efficacious detection tool with a high degree o f predictive value (National Institutes o f Health 1980). The strongest predictor for cervical cancer being diagnosed at a late stage is the lack o f a Pap smear being offered in the last five years before diagnosis. In a case control study in Baltimore, a three-fold odds ratio was identified for this factor (Celentano et al. 1985) . (Celentano et al. 1985) . For treatment following diagnosis, in one study in Buffalo, N .Y ., survival was better for patients treated by gynecologists and surgeons and by doctors who had treated many cervical cancer cases. Expertise and experience also seemed to be an important characteristic o f the hospital/institution providing the treat ment (Graham et al. 1972 ). This problem can be related to the needs of high-risk women, based on a recent study o f emergency rooms and sexually transmitted disease (STD) clinics. In either case, availability of gynecologic services was an exception. As a consequence. Pap smears are not routinely offered as part o f the pelvic examination in STD clinics (Marcus et al. 1986 ). ranged from 30 percent to 66 percent depending on the clinic. This study is now testing an intervention strategy to improve follow-up, which suggests that with relatively minor efforts aimed at improving administrative procedures in clinics, personalized communication with the patient and transportation, major improvements can be made.
These interventions, however, are not a substitute for identifying means to overcome the financial barriers that now exist for needed medical care services.
Quality o f Laboratory Practices.
The Pap smear is a detection tool, not a diagnostic procedure. Increasingly, the laboratory reading of slides is being conducted in specialized cytopathology laboratories, often on a mail-order basis. In the 1970s the Centers for Disease Control conducted a laboratory proficiency study to establish the quality o f these laboratories (Yobs, Swanson, and Lamotte 1985) . This study found significant variations among laboratories including: (a) lack of standardized criteria and classification systems for reading slides and reporting results; (b) inadequate smears being taken and prepared; and (c) cytopathologic reading error. For these reasons, it is likely that error rates may exceed 10 percent.
Policy Considerations
W hen considering strategies to reduce cervical cancer mortality, two distinctions need to be made: (a) strategies to reduce cervical cancer mortality in general in the population, and (b) strategies to reduce the gap in mortality rates between whites and minorities. In this article we are concerned mainly with reducing cervical cancer mortality in the black population.
Race or Economic D isad v a n tag e
There is no known inherent host or biological reason that would explain the excessive cervical cancer rates experienced by blacks. Articles elsewhere in these volumes document both the demographic structure o f the black population-including its disadvantage relative to the white population for a variety o f socioeconomic factors-and the problems that blacks face in seeking access to the health care system. Recently, the American Cancer Society (1986) issued a report which assigned preeminence to economic disadvantage as a major factor explaining the differentials in cancer incidence and mortality rates between blacks and whites. Economic disadvantage certainly can be related to some o f the differentials. It does not, however, explain all o f the differentials in cervical cancer rates between blacks and whites. In fiaict, a major study o f 3,802 invasive cervical cancer cases among white women and 954 cases in black women found that income and education could account for two-thirds o f the incidence difference (Devesa and Diamond 1980) . Likewise, as we have noted earlier, receiving routine Pap smears is not dependent on access to care alone; even in prepaid clinics black women have had lower Pap smear rates in the past (Breslow and Hochstim 1964) and probably still do today. Clearly, factors other than socioeconomic status are related to cervical cancer incidence and mortality and have yet to be identified by well-designed analytic (rather than descriptive) studies. Additionally, the exact nature o f the relation o f income or socioeconomic status to cancer has not been characterized.
M atern al M o rtality -A U sefu l M odel
The application o f the history o f maternal mortality control as a model for secondary prevention o f cancer has been set forth elsewhere (Ringen and Kean 1986) . In the 1930s, responding to the alarming rate o f deaths during childbirth, particularly in the immigrant tenements, public health and preventive medicine activists initiated through their professional organizations measures to define the causes and propose interventions to reduce them (Galdston 1937) . The first o f these studies was conducted in the five boroughs o f New York City under the auspices o f the New York Academy o f Medicine. Every case o f maternal death was tracked down and analyzed by an expert committee in accordance with established standards o f maternity (and perinatal) practice. The committee found that 66 percent o f the deaths could have been avoided, and that, o f these, 6 l percent could be ascribed to provider error and the remaining 39 percent to patient error. A maternal mortality committee was established to review each case in the future and to recommend corrective actions (New York Academy of Medicine 1933). Soon similar committees were established in other communities, and before long maternal death rates began a dramatic decline toward eradication.
Although it would be naive to suggest that this model has direct application to the complexities entailed in cancer control, it provides many useful guidelines, especially related to the control o f cervical cancer. First, by conducting the studies in defined populations, the scientific and demonstration impacts were maximized, and, as an example, strongly influenced the inclusion o f Title V in the Social Security Act o f 1935 for support to perinatal hospital care and other remedies for maternal and infant mortality. Second, the use o f the in-depth retrospective case analysis proved useful to the analysis of relatively rare events in communities. Third, the use o f the expert committees to establish standards o f care and review case material proved to be a powerful vehicle to bridge the gap between scientific and research expertise, on the one hand, and, on the other hand, public health action responsibility. This is not a perfect model. The science was somewhat crude. And in the long run it is unclear whether the continued presence o f permanent maternal committees serves a useful purpose. But there can be no doubt that their initial value was great in terms o f documenting the problem, setting standards of practice, and demonstrating that improvements could be made, and that this model is useful in the context o f control o f cervical cancer (and other cancers) today (Breslow 1984) .
Some P rinciples fo r C erv ical C ancer Control
There are some basic principles that apply to cervical cancer control:
Cervical cancer is a relatively rare event in the population, including among black women. For that reason, a case-finding/management approach seems an essential tool, and it is for this reason the maternal mortality model holds great appeal as an example. Cervical cancer is a " non-contagious" disease. Consequently, there is no constitutional basis for applying the police powers of the state for public health purposes, and there is no basis for compulsory approaches to controlling the disease. This clearly complicates the use o f the case-finding/management approach. In the absence o f compulsory authority, as well as in light of the limitations on financing and access to medical care, there is no basis on which to propose population-based screening in the formal sense o f the word " screening," that is, the ability to achieve complete case ascertainment.
Early detection, as implied in screening, is not the only issue involved in reducing avoidable cervical cancer mortality. A broad range o f activities directed at early detection, continuity, improved quality, and compliance are required. This means that a strategy aimed broadly at secondary prevention is more useful than a strategy simply based on screening for early detection.
• To the extent that cervical cancer mortality is avoidable, it must be recognized that both providers and individuals at risk have responsibilities. Recognition that cervical cancer is symptomatic of long-standing and deep-rooted problems in the relation between medical care provider and medical care consumer is essential.
Recommendations
Within the framework suggested above, a number o f recommendations can be made which should help reduce the rates o f cervical cancer mortality. These recommendations exclude approaches to medical care financing and improvements in access to care since others in these volumes cover these subjects extensively. Our concern is with improving the delivery and use o f detection and follow-up services. Service Delivery. The following changes could be made immediately without changes in financing:
Pap test recommendations. Table 5 records the major sets o f recommendations that now exist with regard to Pap testing. None of these sets is identical, and there is a great deal o f confusion about the best recommendations. O f particular concern is the widespread belief that Pap testing should not apply to elderly women or women over the age o f 60. The age-standardized data on cancer in figure 1 clearly indicate that this is not an appropriate recommendation. Black women, in particular, experience high rates o f both incidence and mortality after the age o f 60, and should continue to receive Pap smears regularly, even after men opause. The respective professional societies should achieve agreement on this subject immediately. Laboratory standardization and quality control. 
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can be little doubt that the laboratory error rates could be reduced significantly, and this again is within the purview of the professional societies.
• (Greenwald, Nasca, and Gordon 1972) .
Data Needs. Extensive data exist to describe the cervical cancer patterns in the United States. Nevertheless, data needs exist, especially in the following areas:
Uniform definitions o f numerators and denominators. For nu merators, agreement on how to classify and include early lesions is especially important; this relates to the pathology classification systems above. For denominators, the age groups-especially the lower age cut-off needs to be standardized. Also, denominators should control for varying rates o f total hysterectomies, which has emerged as a major secular trend in the last thirty years.
Analysis by stage o f disease. Rather than reporting overall rates.
rates by stage o f disease would be more useful for policy purposes. Because advanced-stage disease is associated with the poorest survival, this is a major concern to policy formulations that seek to reduce mortality. At the same time, however, analysis o f data by stage reduces the number o f cases and, thereby, the statistical power significantly, which suggests the need for innovative ways of aggregating data geographically or over time.
• Age-specific reporting. Age-specific rates may be more useful to policy development than age-adjusted or age-standardized rates, since these methods tend to dilute age-related variations. For instance, we have noted that recommendations for Pap testing have " cut-offs" at ages 60 to 65 in many cases. Clearly, the agespecific rates for black women, in particular, indicate the need to eliminate this cut-off, something that age-adjusted or agestandardized rates would not indicate.
Basic Research Needs.
There is a critical need to conduct studies on the contribution o f transmittable viral agents and viral titers in relation to cancer prevention and control. Human papilloma virus studies would be useful. O f concern is carrier status and transmission for both men and women, and the potential for vaccine development to control this risk factor. A major area in need o f both laboratory and analytic epidemiology study is the identification and control of precursors to advanced disease. Special population segments. Populations in need o f special emphasis in terms o f cancer control interventions include, in addition to blacks, the following: native Americans, whose rates approximate those experienced by blacks; older women who stop using gyne cological services; and rural populations, for whom little research has taken place. Alternative delivery modes. The significance attached to convenience in effective detection programs and the problems o f maintaining continuity in follow-up and over time suggest the need to explore alternative approaches to delivering detection services. The possibility of offering Pap testing as part o f occupational medical services needs to be studied at a time when participation by women in the work force is growing. Organizing programs within the auspices of social service agencies, child care centers, churches, etc. have been suggested as means to providing, promoting, or offering referral to detection and treatment services. The need to determine the potential coverage by such programs is critical. It is just as important to know who such programs will reach effectively as who they will not reach.
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Conclusions
Although a relatively rare event, cervical cancer demonstrates a clear social inequity between blacks and whites. While a significant proportion of this inequity can be attributed to blacks being overrepresented in the low socioeconomic categories compared with whites, low socio economic status cannot explain the entire disparity. There does not appear to be any inherent biological reason for the differences in cervical cancer rates between blacks and whites. Consequently, race as a sociological factor must be implicated.
For incidence rates the difference is about two-fold. For mortality rates, the difference is about three-fold. W hile these rates for both blacks and whites have declined over time, the differentials have not changed much. This suggests that both the socioeconomic and racial discrimination factors that may account for these differences have persisted over time.
The need for special efforts aimed at cervical cancer control should remain a public health priority. A broad range o f measures need to be implemented, including changes in classification systems for pa thology, improved laboratory standardization, proficiency testing and quality control, and delivery o f services. It is apparent that many changes that would improve detection and follow-up care could be implemented at little additional cost, such as changing procedures in outpatient clinics and inpatient settings and providing Pap smears in sexually transmitted disease clinics. Such efforts w ould'be likely to benefit black women especially because o f their lower frequency of Pap smears and greater reliance on outpatient clinics and emergency rooms.
It is not possible to predict the impact o f an effective public health program o f cervical cancer in the United States today. By one estimate in New York State based on data from the late 1960s, however, the simple practice o f assuring that all hospitalized women received Pap smears (and were followed up) could reduce deaths from cervical cancer by 50 percent (Greenwald, Nasca, and Gordon 1972) . Thus, a benchmark o f reducing cervical cancer death rates by 50 percent is conservative in the overall population, and very conservative in the black population where the base-line o f avoidable mortality is highest.
